Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 7/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.38 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.35 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.35 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.34 |
| ▸ | MAT2A | P31153 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31095224 | 0.82 | HSD11B1 (0.43) | NFE2L2KDM4ETRIM24TRIM33NAPRT | |
| SCHEMBL31095207 | 0.82 | HSD11B1 (0.43) | NFE2L2KDM4ETRIM24TRIM33NAPRT | |
| SCHEMBL8486922 | 0.79 | NAPRT (0.48) | NFE2L2KDM4ETRIM24TRIM33NAPRT | |
| SCHEMBL8486928 | 0.79 | NAPRT (0.48) | NFE2L2KDM4ETRIM24TRIM33NAPRT | |
| SCHEMBL31095177 | 0.73 | NFE2L2 (0.42) | NFE2L2TRIM24TRIM33NAPRT | |
| SCHEMBL31095221 | 0.73 | NFE2L2 (0.42) | NFE2L2KDM4ETRIM24TRIM33NAPRT | |
| SCHEMBL31095185 | 0.69 | NFE2L2 (0.53) | NFE2L2KDM4ETRIM24TRIM33NAPRT | |
| SCHEMBL29960587 | 0.69 | — | — | |
| SCHEMBL379702 | 0.69 | — | — | |
| SCHEMBL20959864 | 0.66 | NPC1 (0.57) | KDM4ERAB9AGRM4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680602-A1 | HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS | Miralinc Pharma, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024192237-A1 | HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS | MIRALINC PHARMA, INC. (US) | 2024-09-19 | — | — | WO | disclosed |